Corcept Therapeutics has an Enterprise Value (EV) of 5.08B.
7.53
37.1
25.65
25.94
Financial Position
The company has a current ratio of 3.35,
with a Debt / Equity ratio of 0.01.
3.35
3.26
0.01
0.05
0.04
0
Financial Efficiency
Return on Equity is 20.56% and Return on Invested Capital is 17.09%.
20.56%
16.62%
17.09%
$1.35M
$279.47K
500
0.8
0.88
Taxes
20.28M
12.56%
Stock Price Statistics
The stock price has increased by 101.75% in the
last 52 weeks. The beta is 0.29, so Corcept Therapeutics's
price volatility has been higher than the market average.
0.29
101.75%
70.67
65.94
44.93
1,045,720
Income Statement
In the last 12 months, Corcept Therapeutics had revenue of 675.04M
and earned 139.73M
in profits. Earnings per share was 1.35.